ArticleIn vivo (Athens, Greece)

Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma.

Toru Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.